Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jordi Vidal Rodriguez"'
Autor:
Roderick L. Beijersbergen, Lodewyk F.A. Wessels, Cor Lieftink, Jordi Vidal Rodriguez, Katarzyna Jastrzebski, Hayssam Soueidan, Jos B. Poell, Klaas de Lint
Supplementary Figure 1 | IGF1R inhibition by NVP-AEW541 increases sensitivity to PI3K inhibition by GDC-0941 in HCC1806 and CAL-51 cells Supplementary Figure 2 | GDC-0941 dose-response curves of the TNBC cell line panel at different concentrations of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c0ca6d4b0ede50a313d14a20fed4e5f
https://doi.org/10.1158/1535-7163.22508080.v1
https://doi.org/10.1158/1535-7163.22508080.v1
Autor:
Roderick L. Beijersbergen, Lodewyk F.A. Wessels, Cor Lieftink, Jordi Vidal Rodriguez, Katarzyna Jastrzebski, Hayssam Soueidan, Jos B. Poell, Klaas de Lint
RNAseq read counts of IGF1R related genes in the TNBC cell line panel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b89d521dc67d530f1514e1342a40bffd
https://doi.org/10.1158/1535-7163.22508071
https://doi.org/10.1158/1535-7163.22508071
Autor:
Roderick L. Beijersbergen, Lodewyk F.A. Wessels, Cor Lieftink, Jordi Vidal Rodriguez, Katarzyna Jastrzebski, Hayssam Soueidan, Jos B. Poell, Klaas de Lint
Legends Supplemental Figures 1-9 and Tables 1-5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5cf1e3fe9b7bd168f203094127e2456
https://doi.org/10.1158/1535-7163.22508083.v1
https://doi.org/10.1158/1535-7163.22508083.v1
Autor:
Roderick L. Beijersbergen, Lodewyk F.A. Wessels, Cor Lieftink, Jordi Vidal Rodriguez, Katarzyna Jastrzebski, Hayssam Soueidan, Jos B. Poell, Klaas de Lint
Oligonucleotide sequences used in PCR reactions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37c47e27be429ed51140ebd04ba17069
https://doi.org/10.1158/1535-7163.22508074.v1
https://doi.org/10.1158/1535-7163.22508074.v1
Autor:
Roderick L. Beijersbergen, Lodewyk F.A. Wessels, Cor Lieftink, Jordi Vidal Rodriguez, Katarzyna Jastrzebski, Hayssam Soueidan, Jos B. Poell, Klaas de Lint
Normalized counts of shRNA constructs in GDC-0941-exposed and control populations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58cfc9cfcfd09b15af11359c962c1872
https://doi.org/10.1158/1535-7163.22508068
https://doi.org/10.1158/1535-7163.22508068
Autor:
Roderick L. Beijersbergen, Lodewyk F.A. Wessels, Cor Lieftink, Jordi Vidal Rodriguez, Katarzyna Jastrzebski, Hayssam Soueidan, Jos B. Poell, Klaas de Lint
The correlation between Î"AUC and IGF1R mRNA and protein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6c6c4a88c886a9fcc56bd412cd7f83e
https://doi.org/10.1158/1535-7163.22508065.v1
https://doi.org/10.1158/1535-7163.22508065.v1
Autor:
Roderick L. Beijersbergen, Lodewyk F.A. Wessels, Cor Lieftink, Jordi Vidal Rodriguez, Katarzyna Jastrzebski, Hayssam Soueidan, Jos B. Poell, Klaas de Lint
Manually curated set of IGF1R- and PI3K-related genes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ccccdc8bb6aaa1c0c07dd42a968f38c
https://doi.org/10.1158/1535-7163.22508062
https://doi.org/10.1158/1535-7163.22508062
Autor:
Katarzyna Jastrzebski, Jos B Poell, Lodewyk F. A. Wessels, Cor Lieftink, Jordi Vidal Rodriguez, Hayssam Soueidan, Roderick L. Beijersbergen, Klaas de Lint
Publikováno v:
de Lint, K, Poell, J B, Soueidan, H, Jastrzebski, K, Vidal Rodriguez, J, Lieftink, C, Wessels, L F A & Beijersbergen, R L 2016, ' Sensitizing Triple-Negative Breast Cancer to PI3K Inhibition by Cotargeting IGF1R ', Molecular Cancer Therapeutics, vol. 15, no. 7, pp. 1545-56 . https://doi.org/10.1158/1535-7163.MCT-15-0865
Molecular Cancer Therapeutics, 15(7), 1545-56. American Association for Cancer Research Inc.
Molecular Cancer Therapeutics, 15(7), 1545-56. American Association for Cancer Research Inc.
Targeted therapies have proven invaluable in the treatment of breast cancer, as exemplified by tamoxifen treatment for hormone receptor–positive tumors and trastuzumab treatment for HER2-positive tumors. In contrast, a subset of breast cancer negat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8065cdd18d9005dd8fbb1f4efbdb94fa
https://pubmed.ncbi.nlm.nih.gov/27196766
https://pubmed.ncbi.nlm.nih.gov/27196766
